Profile
Christian Meyer is currently the Chief Operating Officer at VectivBio Holding AG since 2021.
He is also currently the Chief Operating Officer at VectivBio AG.
Previously, he held the position of Principal at Novo Nordisk A. From 2006 to 2010, he worked at Symphogen A as the VP-Clinical Research, Medical & Regulatory Affairs.
During the same period, he was also the Chief Medical Officer at RSPR Pharma AB. From 2013 to 2017, he served as the Chief Medical Officer at uniQure NV.
From 2017 to 2019, he held the position of Chief Medical Officer at Therachon Holding GmbH.
Additionally, he is the Chief Development Officer at Therachon AG.
Dr. Meyer obtained his doctorate degree from the University of Copenhagen.
Christian Meyer active positions
| Companies | Position | Start |
|---|---|---|
VectivBio AG
VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Chief Operating Officer | - |
Former positions of Christian Meyer
| Companies | Position | End |
|---|---|---|
Therachon Holding GmbH
Therachon Holding GmbH BiotechnologyHealth Technology Develops medical treatments for rare conditions | Chief Tech/Sci/R&D Officer | 2019-05-31 |
| UNIQURE N.V. | Chief Tech/Sci/R&D Officer | 2017-10-31 |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Chief Tech/Sci/R&D Officer | 2009-12-31 |
Therachon AG | Corporate Officer/Principal | - |
| VECTIVBIO HOLDING AG | Chief Operating Officer | - |
Training of Christian Meyer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
RSPR Pharma AB
RSPR Pharma AB Pharmaceuticals: MajorHealth Technology Develops therapeutics for inflammatory vascular diseases | Health Technology |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Therachon Holding GmbH
Therachon Holding GmbH BiotechnologyHealth Technology Develops medical treatments for rare conditions | Health Technology |
Therachon AG | |
VectivBio Holding AG
VectivBio Holding AG Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for rare diseases | Health Technology |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
- Stock Market
- Insiders
- Christian Meyer
















